In this article, we will look at the 10 Best Australian Stocks to Buy According to Billionaires.
Australian Market Outlook 2025
In December 2024, Ausbil Investment Management Limited released its equity market outlook 2025. Ausbil anticipates Australia’s economic growth will improve heading into 2025, supported by global monetary easing and Australia’s low unemployment rates. It foresees the Reserve Bank of Australia (RBA) potentially reducing rates in 2025, aligning with other central banks, which could boost earnings growth and revitalize cyclical demand. Moreover, the report also expects earnings growth across various sectors to exceed market expectations. However, geopolitical risks, particularly potential trade wars under a newly elected President Trump, pose the most significant threat. If you want to read more about the recent tariffs imposed by the US you can look at the 10 Most Undervalued High Quality Stocks to Buy According to Analysts and 11 Best Undervalued Stocks to Invest in Now.
Ausbil’s general outlook is that a Trump presidency will favor business and markets, but trade changes could cause disruptions and opportunities. It identifies potential in several sectors and expects earnings growth to surpass consensus estimates in FY25. In contrast to widespread recession predictions since late 2023, Ausbil has maintained a more positive view. Australia’s GDP is projected to recover in the latter half of 2024, averaging 1.4%, and further increase to a trend pace of 2.5% in 2025. Household consumption is expected to contribute less of a drag on economic activity. On the other hand, while the labor market remains strong, a slight increase in the unemployment rate to 4.2% is anticipated as labor supply grows and demand relatively slows. Despite this, the economy is expected to maintain its broad-based gains over the past 50 years, which is good news for companies whose earnings depend on household spending. The report expects that the structural demand for resources and a favorable interest rate differential should strengthen the Australian dollar, with forecasts predicting it will rise to US70 cents and the trade-weighted basket will increase.
Ausbil expects that Australia’s global interest rate participation will ease in 2025, which is anticipated to support high-quality resource and energy companies. Moreover, the report also expects the earnings growth to recover more than the market anticipates in FY25, broadening across sectors and market capitalization. The FY24 reporting season was weak due to high inflation, higher interest rates, and softness in China. However, looking to 2025, the report foresees relief for balance sheets and income statements from the RBA potentially starting to ease monetary policy, joining other developed markets, which would reduce debt costs.
With that let’s take a look at the 10 best Australian stocks to buy according to billionaires.
Source: pexels
Our Methodology
To curate the list of the 10 best Australian stocks to buy according to billionaires, we used the Finviz stock screener and Insider Monkey’s billionaire Q4 2024 database. Using the screener we aggregated a list of Australian stocks. Next, we checked the number of billionaires holding each stock and ranked them in ascending order of the number of holders. We have also added the total value of holdings along with the number of hedge funds holding each stock, sourced from Insider Monkey’s Q4 2024 hedge funds database.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
10 Best Australian Stocks to Buy According to Billionaires
10. Nova Minerals Limited (NASDAQ:NVA)
Number of Hedge Fund Holders: 1
Number of Billionaire Investors: 1
Total Value of Billionaire Holdings: $367,773
Nova Minerals Limited (NASDAQ:NVA) is an Australian company that explores and develops mineral properties, focusing on gold, antimony, and critical minerals. The company’s primary project is the Estelle Gold Project in Alaska, which spans 514 square kilometers and features a 35-kilometer mineralized corridor with over 20 gold and antimony prospects.
During the December 2024 quarterly update, the company in a strategic move sold its entire 6.6 million shares in Snow Lake Resources for $6.73 million. Management noted that a portion of the proceeds, around $4 million, was allocated to reduce the Nebari loan. It is considering a smaller-scale operation at the high-grade RPM deposit for potential near-term cash flow and is also open to a larger mining operation with increased gold production that would be of interest to strategic partners. Moreover, Nova Minerals Limited (NASDAQ:NVA) generated $271,000 in revenue during the year and had approximately $A16 million in cash in early January 2025. It is one of the best Australian stocks to buy according to billionaires.
9. Alterity Therapeutics Limited (NASDAQ:ATHE)
Number of Hedge Fund Holders: 1
Number of Billionaire Investors: 1
Total Value of Billionaire Holdings: $107,995
Alterity Therapeutics Limited (NASDAQ:ATHE) is an Australian biotechnology company that creates treatments for neurodegenerative diseases like Parkinson’s and Multiple System Atrophy. Its primary drug, ATH434, aims to prevent the accumulation of harmful proteins in the brain that cause these diseases.
On March 2, Maxim Group analyst Jason McCarthy maintained a Buy rating on the stock with a price target of $12. The analyst noted that the Buy rating is because of the strong financial position and encouraging clinical trial results. The company has strengthened its financial standing by raising funds, which is expected to last through 2026. Moreover, McCarthy also highlighted that Alterity Therapeutics Limited (NASDAQ:ATHE) drug, ATH434, showed positive results in Phase 2 trials for multiple system atrophy (MSA), reducing iron accumulation in the brain and improving functional outcomes. It is one of the best Australian stocks to buy according to billionaires.
8. Mesoblast Limited (NASDAQ:MESO)
Number of Hedge Fund Holders: 2
Number of Billionaire Investors: 1
Total Value of Billionaire Holdings: $3.56 million
Mesoblast Limited (NASDAQ:MESO) is an Australian company that creates and sells unique cell-based medicines to treat severe inflammatory conditions. It uses specialized technology to develop these “off-the-shelf” treatments. The company deals in cell-based medicines, inflammatory conditions, and off-the-shelf treatments.
On March 1, Jason McCarthy from Maxim Group maintained a Buy rating on the stock with a price target of $30. The analyst noted that the price of Ryoncil (the mesenchymal stromal cell therapy approved by the FDA) is approximately $1.55 million per treatment, which is justifiable due to its significant economic benefits. McCarthy believes that Ryoncil is a promising treatment for pediatric steroid-refractory acute graft vs host disease (SR-aGvHD), with a total addressable market of around $600 million. Moreover, the analyst also mentioned that Mesoblast Limited (NASDAQ:MESO) has secured $161 million through a private placement, which should support the commercialization of Ryoncil in the US. Considering the pipeline of the company, including a potential accelerated filing for Rexlemestrocel-L in Class IV heart failure, increases its valuation potential. Mesoblast Limited (NASDAQ:MESO) is one of the best Australian stocks to buy according to billionaires.
7. Locafy Limited (NASDAQ:LCFY)
Number of Hedge Fund Holders: 2
Number of Billionaire Investors: 1
Total Value of Billionaire Holdings: $822,949
Locafy Limited (NASDAQ:LCFY) is a software-as-a-service (SaaS) technology company that specializes in local search engine marketing. It develops and commercializes online marketing technology that is delivered in an automated manner. The company operates through two main segments including Publishing and SEO Agency.
Locafy Limited (NASDAQ:LCFY) is shifting towards AI-powered publishing solutions to enhance local SEO, with a focus on automating content creation and expanding its market reach through strategic partnerships. During the fiscal first quarter of 2025, the company announced that it has integrated its article publishing solution into its platform. Previously, their Article Accelerator technology was used on third-party websites, but changes in Google’s policies made that approach unviable. However, now the company can create, publish, and boost articles within its ecosystem using its technology and expertise.
Locafy Limited (NASDAQ:LCFY) reported a 27.8% year-over-year decrease in total operating revenue, mainly due to its subscription revenue falling by 25.6% during the same time. On the bright side, its Services revenue increased by 80.3%. Management noted that the company has partnered with diDNA to use its advanced advertising technology across its directory portfolio, which will maximize revenue opportunities. It is one of the best Australian stocks to buy according to billionaires.
6. Immutep Limited (NASDAQ:IMMP)
Number of Hedge Fund Holders: 2
Number of Billionaire Investors: 2
Total Value of Billionaire Holdings: $38,671
Immutep Limited (NASDAQ:IMMP) is a clinical-stage biotechnology company based in Australia that specializes in developing Lymphocyte Activation Gene immunotherapies for cancer and autoimmune diseases. On March 7, Canaccord Genuity analyst Elyse Shapiro maintained a Buy rating on the stock with a price target of A$0.95.
During the fiscal second quarter of 2025, the company announced that its TACTI-004 trial, a Phase III study in first-line non-small cell lung cancer (1L NSCLC), has received its first regulatory approval, marking the company’s transition to a Phase III biotech company. Moreover, mature data from the INSIGHT-003 trial in 1L NSCLC demonstrates a 32.9-month median overall survival and an 81.0% 24-month overall survival rate, which significantly outperforms historical controls. Immutep Limited (NASDAQ:IMMP) has a strong cash position, with A$159.26 million in aggregate cash, cash equivalents, and term deposits, providing an expected cash reach to the end of CY2026. It is one of the best Australian stocks to buy according to billionaires.
5. Tamboran Resources Corporation (NYSE:TBN)
Number of Hedge Fund Holders: 4
Number of Billionaire Investors: 2
Total Value of Billionaire Holdings: $12.51 million
Tamboran Resources Corporation (NYSE:TBN) is a natural gas company that is committed to contributing to the global energy transition by producing natural gas in the Beetaloo Basin. The company focuses on supporting the net-zero carbon dioxide energy transition in Australia and the Asia-Pacific region through developing low CO2 unconventional gas resources in the Northern Territory of Australia.
On February 13, Jeff Grampp from Alliance Global Partners reiterated a Buy rating on the stocks with a price target of $32. Tamboran Resources Corporation (NYSE:TBN) has made considerable progress in drilling operations, notably with the SS-2H ST1 and SS-3H wells. The SS-3H well reached a record horizontal section within the Mid Velkerri B Shale. Moreover, the company also completed the drilling and stimulation of the SS-2H ST1 well, achieving new performance records in the Beetaloo Basin.
In a major infrastructural development, the company entered into binding agreements with APA Group to develop essential pipeline infrastructure and secured a $23 million line of credit from Macquarie Bank to support these initiatives. The company is focused on achieving first gas production by 2026, with infrastructure projects progressing on schedule. It is one of the best Australian stocks to buy according to billionaires.
4. Opthea Limited (NASDAQ:OPT)
Number of Hedge Fund Holders: 4
Number of Billionaire Investors: 3
Total Value of Billionaire Holdings: $8.87 million
Opthea Limited (NASDAQ:OPT) is an Australian biopharmaceutical company that focuses on creating new treatments for eye diseases like wet age-related macular degeneration and diabetic macular edema. Its main product, sozinibercept, is undergoing Phase 3 clinical trials to test its effectiveness when combined with standard treatments for wet age-related macular degeneration and diabetic macular edema.
On March 3, JonesTrading analyst Debanjana Chatterjee maintained a Buy rating on the stock with a price target of $13. Chatterjee is optimistic about the Phase 3 trials, which are expected to provide significant data in early to mid-2025. The analyst is confident that sozinibercept will demonstrate vision improvement, especially when combined with aflibercept. Moreover, the analyst also views Opthea Limited’s (NASDAQ:OPT) financial position as robust, with $131.9 million in cash and equivalents, which should last into the third quarter of 2025. This supports the potential for a Biologics License Application (BLA) filing in the first half of 2026 and a possible U.S. launch in 2027. It is one of the best Australian stocks to buy according to billionaires.
3. Woodside Energy Group Ltd (NYSE:WDS)
Number of Hedge Fund Holders: 10
Number of Billionaire Investors: 4
Total Value of Billionaire Holdings: $16.0 million
Woodside Energy Group Ltd (NYSE:WDS) is a global energy company based in Australia. It produces and sells energy. The operations of the company are divided into three main areas including the Australian segment, the International segment, and Marketing. On February 26, Morgans’ analyst Adrian Prendergast maintained a Buy rating on the stock with a price target of A$30.25.
In fiscal 2024, the company achieved a record production of 193.9 million barrels of oil equivalent (MMboe) for 2024, which translates to 530 Mboe/day. This was supported by strong performance from the Sangomar project and high reliability (98%) from their LNG assets. Moreover, the company’s Net Profit After Tax increased by 115% year-on-year, reaching $3,573 million.
Woodside Energy Group Ltd (NYSE:WDS) reported that its Sangomar project ramped up to full capacity within nine weeks of its startup in June 2024 and achieved 94% reliability in the fourth quarter. The project contributed 12.9 million boe in sales, generating approximately $950 million in revenue. It is one of the best Australian stocks to buy according to billionaires.
2. BHP Group Limited (NYSE:BHP)
Number of Hedge Fund Holders: 28
Number of Billionaire Investors: 7
Total Value of Billionaire Holdings: $1.14 billion
BHP Group Limited (NYSE:BHP) is an Australian multinational mining and metals company headquartered in Melbourne. It is one of the world’s largest mining companies based on market capitalization. The company specializes in the mining and selling of commodities, including iron ore, copper, coal, nickel, and potash. On March 7, Morgan Stanley analyst Rahul Anand maintained a Buy rating on the stock with a price target of A$48.50.
For the year ending in June 2024, the company reported a 3% revenue increase to $55.7 billion, mainly due to high iron ore and copper prices. However, attributable profit sharply dropped by almost 39%, from $12.9 billion in 2023 to $7.9 billion in 2024, due to lower energy coal and nickel prices. Moreover, during the first half of 2025, copper production increased by 10% year-over-year and iron ore production improved by 2% quarter-over-quarter. Higher iron ore production was aided by enhanced supply chain management; however, weaker demand from China remains a prominent concern. It is one of the best Australian stocks to buy according to billionaires.
1. IREN Limited (NASDAQ:IREN)
Number of Hedge Fund Holders: 44
Number of Billionaire Investors: 9
Total Value of Billionaire Holdings: $61.1 million
IREN Limited (NASDAQ:IREN) is an Australia-based company that owns and operates data centers powered by 100% renewable energy. Its facilities are optimized for Bitcoin mining, AI cloud services, and other power-dense computing processes. The company not only provides security to the Bitcoin network, expanding to 57 EH/s in 2025 but also provides cloud computing to AI customers. IREN Limited (NASDAQ:IREN) is expanding capacity to 57 EH/s by H2 2025 and initiating direct-to-chip liquid cooling systems in existing data centers to enable rapid scaling for cloud & colocation opportunities.
The company experienced a 35% drop in share value despite a strong fiscal second quarter 2025 performance. Although the company reported $113 million in sales and a return to profitability, broad market concerns related to weak US manufacturing data and apprehension about tariff policies have negatively impacted the stock. The company is progressing in Bitcoin mining and AI cloud services. Management expects substantial growth despite external market pressures.
During the quarter, IREN Limited (NASDAQ:IREN) mined 1,347 Bitcoins, reflecting a notable increase of 813 bitcoins from the first quarter. On February 13, Lucas Pipes from B.Riley Financial maintained a Buy rating on the stock, with a price target of $21. It is the best Australian stock to buy according to billionaires.
While we acknowledge the potential of IREN Limited (NASDAQ:IREN) to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IREN but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
